Search bioRxiv⌕ Search

Biology subjects

Kamar, J.

Publications and source records attributed to Kamar, J..

2 recordsLinked to original sources

Constitutive ATR Signaling Enforces Domain-Wide Origin Synchrony

Eukaryotic DNA replication relies on organized spatial-temporal domains, yet how neighboring origins are coordinated at the single-molecule level remains unresolved. Combining single-molecule DNA combing with super-resolution microscopy, we demonstrate that during unperturbed early S-phase, adjacent replication origins across diverse vertebrate species fire synchronously as a coordinated unit. This domain-wide temporal harmony is continuously enforced by a baseline, constitutive ATR CHK1 signaling axis that restrains local CDK2 and CDC7 kinase activities. Strikingly, replication stress dismantles this coordination, shifting origin activation toward an asynchronous, replicon-autonomous mode. Mechanistically, stress-induced phosphorylation of the cohesin subunit SMC1A promotes an SMC1A ATR complex that sequesters ATR at stalled replication forks. This localized sequestration creates a regional ATR loss-of-function phenotype, relieving CDK2/CDC7 suppression and driving premature, uncoordinated origin firing. Super-resolution imaging shows that ATR sequestration structurally reorganizes replication foci, converting coordinated clustered foci into fragmented, lower-density clusters. Together, our findings uncover a baseline role for constitutive ATR signaling in enforcing domain synchrony and reveal a molecular switch that dynamically decouples origin activation during genomic stress to safeguard chromosome duplication.

molecular biology↗

Targeting RBM10 deficiency in lung adenocarcinoma

The splicing factor RBM10 is frequently mutated in lung adenocarcinoma (LUAD) (9-25%). Most RBM10 cancer mutations are loss-of-function, correlating with increased tumorigenesis and limiting targeted therapy efficacy in EGFR-mutated lung cancer. Notably, therapeutic strategies leveraging RBM10 deficiency remain unexplored. Hence, we conducted RBM10 CRISPR-Cas9 synthetic lethality (SL) screen and identified [~]250 RBM10 SL genes, including WEE1 kinase. WEE1 inhibition sensitized RBM10-deficient LUAD cells in-vitro and in-vivo. Mechanistically, we identified a splicing-independent role of RBM10 in promoting replication fork progression that underpins RBM10-WEE1 SL. Also, we revealed that RBM10 is associated with active replication forks, which is reliant on PRIM1, an enzyme synthesizing RNA primers for Okazaki fragments. Functionally, we demonstrated that RBM10 serves as an anchor for recruiting HDAC1 and facilitates H4K16 deacetylation to maintain replication fork stability. Collectively, our data revealed a hitherto unrecognized function of RBM10 in fine-tuning DNA replication, and provide therapeutic arsenal for targeting RBM10-deficient tumors.

molecular biology↗